| | | 68143 | | 13.07.2021 | | Incyte Biosciences International Sàrl | | | | | | | 23.07.2030 | | | | | | 07.16.10. | | | | 07.16.10. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Pemazyre 4,5 mg | comprimés | Tablets (Pemigatinibum 4.5 mg) | L01EN02 | CI | | 02 | Pemazyre 9 mg | comprimés | Tablets (Pemigatinibum 9 mg) | L01EN02 | CI | | 03 | Pemazyre 13,5 mg | comprimés | Tablets (Pemigatinibum 13.5 mg) | L01EN02 | CI |
|
|
